Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
99.29
+2.75 (2.85%)
At close: Nov 2, 2026, 4:00 PM EST
98.68
-0.61 (-0.61%)
After-hours: Nov 2, 2026, 4:31 PM EST
Medtronic Financials Overview
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 24, 2026 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 |
Revenue Revenue Growth | 37,542 | 36,364 | 33,537 | 32,364 | 31,227 | 31,686 |
Revenue Growth | 9.77% | 8.43% | 3.62% | 3.64% | -1.45% | 5.21% |
Gross Profit Gross Profit Growth | 24,504 | 23,749 | 21,931 | 21,273 | 20,605 | 21,658 |
Operating Income Operating Income Growth | 7,545 | 7,266 | 6,334 | 6,830 | 5,569 | 6,847 |
Net Income Net Income Growth | 5,231 | 4,801 | 4,662 | 3,676 | 3,758 | 5,039 |
Earnings Per Share EPS Growth | 4.06 | 3.73 | 3.61 | 2.76 | 2.82 | 3.73 |
EPS Growth | 12.12% | 3.32% | 30.80% | -2.13% | -24.40% | 40.23% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 24, 2026 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 |
Cardiac Rhythm & Heart Failure Cardiac Rhythm & Heart Failure Growth | 8,009 | 7,504 | 6,392 | 5,995 | 5,783 | 5,852 |
Structural Heart & Aortic Structural Heart & Aortic Growth | - | 3,817 | 3,554 | 3,358 | 3,363 | 3,055 |
Coronary & Peripheral Vascular Coronary & Peripheral Vascular Growth | - | 2,656 | 2,535 | 2,478 | 2,375 | 2,460 |
Cranial & Spinal Technologies Cranial & Spinal Technologies Growth | 5,377 | 5,222 | 4,973 | 4,756 | 4,451 | 4,456 |
Specialty Therapies Specialty Therapies Growth | 3,069 | 2,997 | 2,940 | 2,905 | 2,815 | 2,592 |
Neuromodulation Neuromodulation Growth | 2,103 | 2,068 | 1,932 | 1,746 | 1,693 | 1,735 |
Surgical & Endoscopy Surgical & Endoscopy Growth | 6,893 | 6,764 | 6,498 | 6,508 | 6,152 | 6,543 |
Acute Care & Monitoring Acute Care & Monitoring Growth | 2,119 | 2,051 | 1,909 | 1,908 | 1,837 | 1,926 |
Diabetes Diabetes Growth | 3,233 | 3,112 | 2,755 | 2,488 | 2,262 | 2,338 |
Other Segment Other Segment Growth | 130 | 174 | 48 | 221 | 495 | 727 |
Revenue (Total) Revenue (Total) Growth | 37,541 | 36,364 | 33,537 | 32,364 | 31,227 | 31,686 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 24, 2026 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 |
Cash & Investments Cash & Investments Growth | 8,982 | 9,350 | 8,982 | 8,033 | 8,074 | 10,637 |
Total Debt Total Debt Growth | 28,153 | 29,149 | 29,626 | 26,047 | 25,413 | 24,984 |
Net Cash (Debt) Net Cash Growth | -19,171 | -19,799 | -20,644 | -18,014 | -17,339 | -14,347 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -14.89 | -15.37 | -16.00 | -13.54 | -13.01 | -10.62 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 24, 2026 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 8,035 | 7,330 | 7,044 | 6,787 | 6,039 | 7,346 |
Capital Expenditures CapEx Growth | -1,903 | -1,904 | -1,859 | -1,587 | -1,459 | -1,368 |
Free Cash Flow Free Cash Flow Growth | 6,132 | 5,426 | 5,185 | 5,200 | 4,580 | 5,978 |
Free Cash Flow Growth | 15.63% | 4.65% | -0.29% | 13.54% | -23.39% | 22.38% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 24, 2026 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 |
Gross Margin | 65.27% | 65.31% | 65.39% | 65.73% | 65.98% | 68.35% |
Operating Margin | 20.10% | 19.98% | 18.89% | 21.10% | 17.83% | 21.61% |
Pretax Margin | 17.59% | 16.88% | 16.78% | 14.95% | 17.18% | 17.41% |
Profit Margin | 13.93% | 13.20% | 13.90% | 11.36% | 12.03% | 15.90% |
FCF Margin | 16.33% | 14.92% | 15.46% | 16.07% | 14.67% | 18.87% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 2, 2026 | Apr '26 Apr 24, 2026 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 |
Dividend Per Share Dividend Per Share Growth | 2.880 | 2.840 | 2.800 | 2.760 | 2.720 | 2.520 |
Dividend Per Share Growth | 1.42% | 1.43% | 1.45% | 1.47% | 7.94% | 8.62% |
Dividend Yield | 2.90% | 3.40% | 3.33% | 3.42% | 2.99% | 2.40% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 2, 2026 | Apr '26 Apr 24, 2026 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 |
PE Ratio | 24.46 | 22.28 | 23.15 | 28.80 | 32.20 | 27.78 |
Forward PE | 16.53 | 14.29 | 14.64 | 14.87 | 17.32 | 18.03 |
P/FCF Ratio | 19.50 | 19.72 | 20.82 | 20.36 | 26.42 | 23.42 |
PS Ratio | 3.18 | 2.94 | 3.22 | 3.27 | 3.88 | 4.42 |